Mizuho Maintains Buy on Tenet Healthcare, Raises Price Target to $110
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes has maintained a Buy rating on Tenet Healthcare (NYSE:THC) and increased the price target from $100 to $110.
March 11, 2024 | 11:37 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho analyst Ann Hynes reaffirmed a Buy rating on Tenet Healthcare and raised the price target to $110 from $100.
The increase in price target by a reputable analyst like Ann Hynes signals a strong confidence in Tenet Healthcare's future performance. This endorsement is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100